Alembic Pharmaceuticals Limited (NSE:APLLTD) — Stock Price

Rs831.35 INR
▲ 0.15% today

Alembic Pharmaceuticals Limited (NSE:APLLTD) is currently trading at Rs831.35 INR, up 0.15% today. Over the past 52 weeks, shares have ranged between Rs646.55 and Rs992.95. This page tracks Alembic Pharmaceuticals Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Alembic Pharmaceuticals Limited stock valuation.

Alembic Pharmaceuticals Limited (APLLTD) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Alembic Pharmaceuticals Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Alembic Pharmaceuticals Limited Income Statement — Revenue, Profit & Earnings by Year

Alembic Pharmaceuticals Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs66.72 Billion Rs62.29 Billion Rs56.53 Billion Rs53.06 Billion Rs53.93 Billion
Cost of Revenue Rs18.81 Billion Rs17.96 Billion Rs17.75 Billion Rs14.98 Billion Rs13.40 Billion
Gross Profit Rs47.91 Billion Rs44.33 Billion Rs38.78 Billion Rs38.08 Billion Rs40.53 Billion
Research & Development Rs5.22 Billion Rs4.75 Billion Rs7.22 Billion Rs8.38 Billion Rs6.70 Billion
SG&A Rs2.80 Billion Rs2.52 Billion Rs2.41 Billion Rs2.11 Billion Rs2.09 Billion
Total Operating Expenses Rs20.90 Billion Rs19.24 Billion Rs18.97 Billion Rs19.77 Billion Rs17.21 Billion
Operating Income Rs27.02 Billion Rs25.08 Billion Rs19.81 Billion Rs18.31 Billion Rs23.32 Billion
EBITDA Rs9.89 Billion Rs9.14 Billion Rs6.96 Billion Rs8.59 Billion Rs14.66 Billion
EBIT Rs7.30 Billion Rs6.61 Billion Rs4.38 Billion Rs5.87 Billion Rs12.97 Billion
Interest Expense Rs787.70 Million Rs561.90 Million Rs501.70 Million Rs177.30 Million Rs160.20 Million
Income Before Tax Rs7.07 Billion Rs6.32 Billion Rs3.55 Billion Rs6.25 Billion Rs14.00 Billion
Income Tax Expense Rs1.25 Billion Rs160.10 Million Rs126.00 Million Rs1.04 Billion Rs2.53 Billion
Net Income Rs5.83 Billion Rs6.16 Billion Rs3.42 Billion Rs5.21 Billion Rs11.46 Billion

Alembic Pharmaceuticals Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Alembic Pharmaceuticals Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs77.73 Billion Rs64.46 Billion Rs61.83 Billion Rs71.22 Billion Rs67.09 Billion
Total Current Assets Rs40.88 Billion Rs30.79 Billion Rs29.10 Billion Rs28.61 Billion Rs26.52 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs181.50 Million Rs271.30 Million Rs166.40 Million Rs316.20 Million Rs1.87 Billion
Net Receivables Rs14.00 Billion Rs10.25 Billion Rs10.51 Billion Rs8.11 Billion Rs3.54 Billion
Inventory Rs22.88 Billion Rs16.44 Billion Rs14.75 Billion Rs16.10 Billion Rs14.86 Billion
Property, Plant & Equipment Rs33.61 Billion Rs30.71 Billion Rs30.00 Billion Rs39.47 Billion Rs36.48 Billion
Goodwill — — — — Rs0.00
Total Liabilities Rs25.83 Billion Rs16.27 Billion Rs18.12 Billion Rs18.84 Billion Rs16.42 Billion
Total Current Liabilities Rs24.12 Billion Rs14.55 Billion Rs16.37 Billion Rs17.17 Billion Rs12.81 Billion
Long-term Debt — — — Rs0.00 Rs2.00 Billion
Net Debt Rs11.67 Billion Rs3.93 Billion Rs6.47 Billion Rs6.56 Billion Rs4.86 Billion
Total Stockholder Equity Rs51.91 Billion Rs48.18 Billion Rs43.70 Billion Rs52.38 Billion Rs50.67 Billion
Retained Earnings Rs43.94 Billion Rs40.27 Billion Rs35.68 Billion Rs25.54 Billion Rs23.85 Billion

Alembic Pharmaceuticals Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Alembic Pharmaceuticals Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs879.70 Million Rs8.03 Billion Rs7.24 Billion Rs5.52 Billion Rs14.63 Billion
Capital Expenditures Rs5.64 Billion Rs3.27 Billion Rs4.43 Billion Rs4.26 Billion Rs6.60 Billion
Free Cash Flow Rs-4.76 Billion Rs4.76 Billion Rs2.81 Billion Rs1.27 Billion Rs8.04 Billion
Investing Cash Flow Rs-5.68 Billion Rs-3.21 Billion Rs-4.48 Billion Rs-3.72 Billion Rs-8.39 Billion
Financing Cash Flow Rs4.44 Billion Rs-4.38 Billion Rs-2.62 Billion Rs-2.17 Billion Rs-5.97 Billion
Dividends Paid Rs2.16 Billion Rs1.57 Billion Rs1.97 Billion Rs2.75 Billion Rs2.75 Billion
Stock-Based Compensation — — — — —
Depreciation Rs2.79 Billion Rs2.73 Billion Rs2.75 Billion Rs2.87 Billion Rs1.83 Billion
Change in Cash Rs-367.30 Million Rs447.30 Million Rs143.90 Million Rs-369.70 Million Rs262.20 Million

Alembic Pharmaceuticals Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Alembic Pharmaceuticals Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 04, 2026 — — —
Feb 05, 2026 8.51 9.14 -6.89%
Nov 04, 2025 9.40 8.70 +8.05%
Aug 05, 2025 7.85 7.83 +0.26%
May 06, 2025 7.98 7.16 +11.45%
Feb 03, 2025 7.01 8.00 -12.38%
Nov 07, 2024 7.24 8.47 -14.52%
Aug 08, 2024 6.84 8.99 -23.92%